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Abstract
For the optimal function of thyroid gland, adequate intakes of iodine and selenium are required. Since iodine is essential component of the thyroid hormones, its 
insufficiency leads to inadequate hormone production and further to inadequate tissue response (hypothyroidism), goitre, stillbirth and miscarriages, and growth 
retardation. According to the World Health Organisation the recommended median urinary iodine concentrations (UIC) are the best indicators of iodine nutrition. 
The WHO defines iodine sufficiency in an adult population as a median UIC of > 100 µg/L in spot urine samples. Iodine deficiency was and still is a problem in New 
Zealand. In September 2009 the mandatory fortification of all bread with iodized salt was introduced. Therefore, the primary aim of the study was to determine the 
levels of iodine in both groups, and the secondary aim of the study was to determine whether there is a relationship between selenium and iodine, and iodine and 
thyroid hormones in two groups of European women. Urinary iodine concentration was determined in spot samples by the new method called “Fast B”, which is 
improved Sandell-Kolthoff reaction. The results of the study showed the mean urinary iodine level in the control group and the group of women with the Hashimoto’s 
thyroiditis was 120.77± 59.35 (median UIC was128.00 µg/L), and 98.64 ± 62.83 (median UIC was 95.00 µg/L), respectively. Estimated daily iodine intake of 150µg/
day was achieved in five participants in the control group, and four participants in the group of women with Hashimoto’s thyroiditis. Estimated median iodine intake 
in the control group and Hashimoto’s group was 142.22 and 105.55, respectively, indicating mild iodine deficiency. There was no significant relationships found 
between iodine and selenium, and iodine and thyroid hormones in both groups. The results of the current study are in line with the results from larger studies carried 
out in New Zealand. Iodine intakes appear to have improved after the mandatory fortification of bread with iodised salt in 2009, although iodine deficiency is still a 
problem in New Zealand. Using an iodine fortified bread clearly made an impact on the overall iodine intake but not to the expected level. There was no association 
found between iodine and selenium, and iodine and thyroid hormones. Any possible interaction between selenium and iodine is still unclear.
Introduction 
The synthesis of the major thyroid gland hormone thyroxine 
occurs along the hypothalamic-pituitary-thyroid axis (HPT axis). HPT 
axis represents a complex series of pathways and feedback mechanisms 
[1, 2]. Adequate function of the HPT axis is critically dependent on 
the essential trace elements iodine, selenium and iron, although most 
closely associated are iodine and selenium [3]. The thyroid gland 
contains the highest iodine and selenium concentration among the 
human tissues and organs in the human body. For the optimal function 
of thyroid gland, adequate intakes of iodine and selenium are required 
[4]. Inadequate iodine intake can cause deficiency which might impair 
the synthesis of thyroid hormones, tetra iodothyronine (T4) and 
triiodothyronine (T3), whereas selenium is essential for the synthesis of 
selenoenzymes whose deficiency is implicated in disorders of thyroid 
hormone metabolism, and thyroid gland function. 
The crucial step in thyroid hormone synthesis is the direct 
binding of TSH to the TSH receptors (TSH-Rs). [5]. Iodine is taken 
by thyrocytes from blood plasma through the actions of the integral 
plasma membrane glycoprotein sodium/iodide symporter (NIS), 
which mediates the active transport of iodine into the thyroid follicular 
cells [6]. The next step in thyroid hormone synthesis is the process 
of thyroglobulin (Tg) iodination, which occurs inside the lumen 
of thyroid follicles [7,8]. Thyroglobulin iodination requires iodide 
catalyzed by selenoenzyme thyroid peroxidase (TPO), and higher H2O2 
concentrations generated in the apex of the thyrocytes, where selenium 
exerts one of its vital roles in peroxide degradation, cellular redox 
and transcription regulation, and thyroid hormone deiodination [3]. 
Overall, selenium plays a crucial role in the maintenance of metabolic, 
immune-endocrine, and cellular homeostasis, owing to its antioxidant 
and anti-inflammatory properties[9,10].  Selenium is an integral part of 
the iodothyronine deiodinases (selenoenzymes), that link selenium and 
iodide in a potentially important interrelationship in which one trace 
element might influence the metabolism of another [11]. Synthesized 
entirely by the thyroid gland, T4 acts as a prohormone to generate 
T3. The process of peripheral mono deiodination of T4 provides for 
the remaining 80% of T3 daily production in healthy people, whereas 
thyroid gland itself generates 20% of the T3 [12]. Biologically active 
T3 is essential for normal development, growth, neural differentiation, 
and cellular metabolism [13]. 
Iodine is an essential component of the thyroid hormones, T4 and 
T3, and makes 65% and 59% of their molecular weight respectively 
[14]. For adequate hormone supply, the thyroid gland has developed 
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the moderate selenium deficiency. The plasma contents of selenium, 
TSH, T4, T3, creatinine, and e-GFR (Glomerular Filtration Rate) were 
determined. Any change in the participants' daily routine was not 
required. Plasma TSH, T3, and T4 were measured using competitive 
immunoassays technique by the LabTests Laboratories in Auckland. 
Serum selenium was measured using inductively coupled plasma –
dynamic reaction cell mass spectrometry by the Canterbury Health 
Laboratories in Christchurch, New Zealand. Urine samples were 
frozen and kept on -20°C until analysis. Urinary iodine concentration 
(UIC) was determined in spot samples by the new method called “Fast 
B” at the AUT University Laboratory [28]. Fast B method is improved 
Sandell-Kolthoff reaction, which is simple, rapid, inexpensive, and 
reliable, and flexible [29] .  
Statistical analyses
All statistical analyses were conducted using SPSS for windows 
(version 22.0, SPSS Inc., Chicago, Illinois, USA). Variables in the study 
were normally distributed, although TSH had skewed distribution 
and was log transformed before statistical analyses. Descriptive 
statistics (mean ± S.D, and frequencies) were presented for baseline 
characteristics, while Pearson product-moment correlation coefficient 
investigated the relationships between iodine and selenium, and iodine 
and thyroid hormones in both groups of participants. From UICs, 
estimated daily intake of iodine was calculated. Values with a p< 0.05 
were taken as significant. 
Results 
Women with Hashimoto’s thyroiditis were older than women in 
the control group, 58.09 ± 10.80 and 52.69 ± 7.40 respectively. Both 
groups presented with the moderate selenium deficiency. The mean 
plasma selenium levels in the control group and the group of women 
with the Hashimoto’s thyroiditis were 1.28 ± 0.15, and 1.32 ± 0.17 
respectively. The mean urinary iodine level in the control group and 
the group of women with the Hashimoto’s thyroiditis was 120.77± 
59.35 (median UIC was128.00 µg/L), and 98.64 ± 62.83 (median UIC 
was 95.00 µg/L), respectively. Estimated daily iodine intake of 150µg/
day was achieved in five participants in the control group, and four 
participants in the group of women with Hashimoto’s thyroiditis. 
Estimated median iodine intake in the control group and Hashimoto’s 
group was 142.22 and 105.55, respectively. Pearson correlation analyses 
have shown no significant relationships between iodine and selenium, 
and iodine and thyroid hormones TSH, T4, and T3 in both groups. The 
mean plasma levels of creatinine and eGFR were within optimal ranges 
in both groups. 
Discussion 
This study is based on self-reported presence or absence of thyroid 
disease. Participants in the study were European women (n=24) who 
were self-assigned into the healthy control group (n=13) and a group 
of women with Hashimoto’s autoimmune thyroiditis on medication 
with Levothyroxine (n=11). Both groups presented with the moderate 
selenium deficiency [30]. It has been suggested that maximal activity of 
selenoenzyme is reached at blood selenium levels above 1.27 µmol/L, 
or according to the recent research by Rayman plasma selenium levels 
in the range of 1.6 to 1.9 µmol/L are considered optimal for thyroid 
and overall good health [31].Also the study by Karunasinghe et al. 
(2012)  have suggested that the basic selenium requirement may vary 
with genotype for a number of variations in selenoprotein genes, 
suggesting that an effective dietary selenium intake for one person may 
be different from that for others. In the absence of this information, 
an elaborate mechanism for concentrating iodine from the circulation 
and converting it to T4, which is then stored and released on demand. 
However, iodine insufficiency leads to inadequate hormone production 
and further to inadequate tissue response (hypothyroidism), goitre, 
stillbirth and miscarriages, growth retardation [15]. The most 
devastating toll is of the neurological and mental disorders resulting 
from the brain damage. In order to prevent iodine deficiency, the 
International Council for Control of Iodine Deficiency Disorders, the 
World Health Organisation, UNICEF, and the Food and Nutrition 
Board of the U.S. National Academy of Sciences, recommended dietary 
iodine intake (RDI) of about 150µg/day for adults being essential for 
the thyroid hormone synthesis [16].
Similarly, in Australia and New Zealand, the Estimated Average 
Requirement (EAR) and Recommended Dietary Intake (RDI) for 
adult women for iodine are 100 and 150µg/day. According to the 
World Health Organisation (WHO) and other international groups, 
the recommended median urinary iodine concentrations (UIC) are 
the best indicators of iodine nutrition [17]. The WHO defines iodine 
sufficiency (ID) in an adult population as a median UIC of > 100 
µg/L in spot urine samples, providing no more than 20% of samples 
are >50 µg/L. The ranges where medians fall are far more important 
than the number. The ranges are arranged beginning with the severe 
iodine deficiency (0-19µg/L), moderate deficiency (20-49 µg/L), mild 
deficiency (50-99 µg/L), optimal iodine nutrition (100-199 µg/L), and 
more than adequate iodine intake of (200-299 µg/L), and excessive 
iodine intake (≥ 300 µg/L) [18-20].
The signs and symptoms of ID in New Zealand were notified in the 
late 1800s and early 1900s and were characterized by endemic goiter 
and low UIC of less than 50µg/L. The major contributing factors for ID 
were low iodine concentrations of New Zealand soil and the reduction 
in the use of iodophors by the dairy industry [21].  In the early 1900s in 
order to decrease the incidence of endemic goiter in many parts of New 
Zealand, iodisation of table and cooking salt was introduced in 1924 
at the level of < 40 mg/kg, although it was increased in 1939 to 40-80 
mg/kg [22]. Following this increase in iodisation of salt, the incidence 
of goiter has dropped from 61% to 1.1% in the 1950s. For more than 
two decades iodine intake was adequate or more than adequate, owing 
to iodised table salt use and use of iodophors as equipment sanitizers 
in the dairy industry [23,24]. In the early 1990s, the use of iodophors 
decreased, and recommendations to reduce salt intake raised concerns 
that iodine intake might decrease. The study by Thomson et al. found 
that urine iodine concentrations were considerably lower than those 
previously reported [25]. However, iodine deficiency was and still is a 
problem in New Zealand and parts of Australia [26,27]. In September 
2009 to prevent iodine deficiency, the mandatory fortification of all 
bread with iodized salt was introduced in both countries.
The primary aim of the study was to determine the levels of iodine 
in both groups and compare them with gold standards. The secondary 
aim of the study was to determine whether there is a relationship 
between selenium and iodine, and iodine and thyroid hormones in two 
groups of European women, control group and a group on medication 
with levothyroxine. 
Patients and method 
This study was conducted as a pilot, crossectional and observational. 
Volunteers in the study were 24 European women, who were self - 
assigned into two groups, control group with healthy participants 
(n=13), and a group of women with Hashimoto’s thyroiditis (HT) 
on medication with L-thyroxine (n=11). Both groups presented with 
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recommended plasma selenium levels should be in the range of 1.27 – 
1.90µmol/L [32]. 
Plasma levels of TSH and T4 are higher in the group of women with 
Hashimoto’s thyroiditis (2.92 ± 2.83; 14.27 ±2.45) than in the control 
group (14.62 ±1.45) respectively. On the basis of these measurements, 
it is difficult to draw any conclusion about the iodine nutritional status 
of women in both groups, because TSH and T4 are not proper markers 
of urinary iodine concentrations (UIC) in this study sample [14]. 
However, currently, the most practical marker of community iodine 
nutrition is the median UIC in casual samples (µg/L), since about 
90% of iodine is excreted in urine, which represents an indicator of 
the adequacy of the iodine intake of that population. According to the 
International Council for Control of Iodine Deficiency Disorders, the 
World Health Organisation, UNICEF, and the Food and Nutrition 
Board of the U.S. National Academy of Sciences, the minimal UIC for 
iodine sufficiency was set up at 100 µg/L, which corresponds to a daily 
intake of 150 µg of iodine [33]. Following these recommendations, after 
mandatory fortification of bread with iodised salt in 2009, women in 
the control group had a moderate sufficiency of iodine with the median 
UIC of 128.00µg/day, while women in the Hashimoto’s group had mild 
iodine deficiency with the median UIC of 95.00µg/day. These figures 
suggest that the iodine status of New Zealand adults in this study 
sample is now likely to be adequate for the healthy population (Table 
3 and 4). The UICs below 50th percentile significantly differed between 
the two groups. Below the 20th percentile, women in Hashimoto's group 
had severe iodine deficiency with UIC of 14 µg/L, while women in the 
control group presented with the mild iodine deficiency of 63.80 µg/L 
(Table 2). Estimated median iodine intake in the control group and 
the group of women with Hashimoto’s thyroiditis based on urine was 
142.22 µg/day and 105.55 µg/day respectively, below RDI of 150 µg/day 
in both groups; although, lower in the Hashimoto’s group (Table 1). The 
presence of iodine and selenium deficiencies in this study is supported 
by the study of Brough, et al (2017) with mild ID and low selenium 
intake of postmenopausal women in New Zealand [34]. Median UIC 
was 57 µg/L, while estimated median iodine intake based on urine was 
138 µg/day, below RDI (150 µg/day). Another study by Edmonds et al. 
(2016) notified an improvement in iodine status from a median UIC 
of 53 µg/L reported in the 2008/2009 New Zealand Adult Nutrition 
Survey to 73µg/L in the study, which was far below the recommended 
range by WHO/UNICEF/ICCIDD, although median urinary iodine 
excretion (UIE) of 127 µg/day suggested that overall iodine status was 
likely to be adequate after mandatory fortification of bread in 2009[35].
Continuous changes in the iodine supply to New Zealand population 
through the time, showed that iodine is already established factor in the 
onset of thyroid autoimmunity (TAI) [36]. In susceptible individuals, 
iodine overload causes a paradoxical block of the organification of 
iodide (the so-called Wolff-Chaikoff effect), and of the iodine intra- 
thyrocyte transport by the sodium-iodide symporter (NIS). It was 
shown that iodide-induced hypothyroidism was precipitated by either 
prolonged excessive intracellular iodide concentration, or transition 
from iodine deficiency to iodine sufficiency or excess, that increased 
the incidence of autoimmune thyroiditis (AIT) and hypothyroidism, 
especially in young women [37]. Autoimmune disease affects thyroid 
gland more than any other organ in the body [38,39]. Hashimoto’s 
thyroiditis (HT) is a primary and permanent hypothyroidism, and 
the most common autoimmune disease. Chronic inflammation 
of the thyroid endocrine tissue is the major characteristic of the 
autoimmune process. 
In our study, women with Hashimoto's thyroiditis on medication 
with Levothyroxine, besides moderate selenium deficiency are now 
categorized as a group of women with ID which is less pronounced 
in the group of women without thyroid disorder. In our study, no 
association was found between selenium and iodine, and thyroid 
hormones (Table 5). However, several studies indicated that effects 
of selenium deficiency or excess on thyroid hormone biosynthesis 
in severe ID were more likely to be more pronounced than in mild 
ID [40-43]. Although, according to Rasmussen et al. (2011), optimal 
selenium status might help to prevent iodine deficiency disorders 
(IDD), particularly thyroid gland enlargement. The study by Shukri et 
al. (2014), suggested that severe selenium deficiency may exacerbate 
ID. However, the results from our study are in line with results 
from the larger study carried out in New Zealand [44]. The authors 
suggested that there was no association between plasma selenium and 
thyroid hormones, and selenium deficiency did not significantly affect 
study population with marginal iodine status. These findings might be 
applicable only to the healthy control group in the current study.
Conclusions 
The results of the current study, with a relatively small sample 
size, are in line with the results from larger studies carried out in New 
Zealand. Iodine intakes appear to have improved after the mandatory 
fortification of bread with iodised salt in 2009, although ID is still a 
problem in New Zealand. Using an iodine fortified bread clearly 
made an impact on the overall iodine intake but not to the expected 
Hashimoto's group n=11 Control group n=13
UIC
(µg/L)
EDI of Iodine
(µg/day)
UIC
(µg/L)
EDI of Iodine
(µg/day)
119 132.22 154 171.11
 11   12.22 128 142.22
137 152.22  65   72.22
180 200 128 142.22
 34   37.77  64   71.11
 68   75.55 161 178.88
 95 105.55 176 195.55
 14   15.55 111 123.33
149 165.55  77   85.55
190 211.11 141 156.67
 88   97.77 257 285.56
   63  70
   45  50
Table 1. UIC and estimated dietary intake of iodine in both groups.
Estimated median iodine intake 
Hashimoto's group n=11 Control group n=13
Mean 109.59 134.19
Median 105.55 142.22
Std. Deviation 69.81 65.94
Percentiles
10 12.89 58.00
20 24.44 70.89
25 37.77 71.67
30 60.44 74.89
40 93.33 108.22
50 105.55 142.22
60 136.22 148.00
70 157.55 168.22
75 165.55 175.00
80 186.22 182.21
90 208.89 249.56
Table 2. Means, SDs, and frequencies of estimated median iodine intake in both groups.
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 Age TSH T3 T4 T3/T4r Selenium Iodine
Mean 58.09 2.92 4.42 14.27 0.32 1.32 98.64
Median 57.00 1.60 4.40 15.00 0.30 1.28 95.00
Std. Deviation 10.80 2.83 0.66 2.45 0.07 0.17 62.83
Percentiles
10 40.80 0.64 3.54 10.20 0.23 1.12 11.60
20 48.80 0.73 3.86 11.40 0.25 1.17 22.00
25 50.00 0.81 4.10 12.00 0.27 1.19 34.00
30 52.40 0.92 4.10 13.20 0.28 1.21 54.40
40 55.60 1.40 4.26 14.00 0.28 1.25 84.00
50 57.00 1.60 4.40 15.00 0.30 1.28 95.00
60 62.40 2.98 4.52 15.00 0.32 1.32 122.60
70 64.00 3.86 4.60 15.40 0.37 1.42 141.80
75 64.00 4.70 4.60 16.00 0.38 1.45 149.00
80 64.60 4.88 4.72 16.60 0.40 1.47 167.60
90 77.00 9.00 5.76 17.80 0.43 1.65 188.00
Table 3. Variables presented as means, SDs, median, and frequencies (Hashimoto’s group).
 Age TSH T3 T4 T3T4ratio Selenium Iodine
Mean 52.69 2.07 4.76 14.62 0.33 1.28 120.77
Median 54.00 2.10 4.90 14.00 0.34 1.29 128.00
Std. Deviation 7.40 0.41 0.58 1.45 0.05 0.15 59.35
Percentiles
10 40.60 1.44 4.02 12.40 0.26 1.04 52.20
20 46.00 1.58 4.20 13.80 0.26 1.12 63.80
25 46.50 1.70 4.20 14.00 0.28 1.14 64.50
30 47.80 1.86 4.26 14.00 0.30 1.16 67.40
40 52.20 2.10 4.62 14.00 0.32 1.26 97.40
50 54.00 2.10 4.90 14.00 0.34 1.29 128.00
60 54.40 2.20 4.90 14.80 0.35 1.34 133.20
70 55.80 2.20 5.06 16.00 0.35 1.37 151.40
75 58.50 2.23 5.10 16.00 0.36 1.38 157.50
80 61.00 2.30 5.12 16.00 0.36 1.41 164.00
90 62.80 2.74 5.74 16.60 0.41 1.51 224.60
Table 4. Variables presented as means, SDs, median, and frequencies (Control group).
Pearson Correlation Control group n=13 Hashimoto's group n=11
Coefficient Selenium Iodine Selenium Iodine
Age
 -.026 .291 -.013 -.006
Sig. .934 .335 .969 .985
TSH
 -.095 .275 -.040 .107
Sig. .757 .363 .908 .754
T3
 .006 -.169 .475 -.216
Sig. .986 .580 .140 .523
T4
 -.022 .206 .275 -.140
Sig. .942 .500 .413 .681
Selenium
 -.173 -.252
Sig. .571 .454
Iodine
 -.173 -.252
Sig. .571 .454
T3/T4ratio
 .021 -.248 .037 .009
Sig. .945 .414 .914 .980
**. Correlation is significant at the 0.01level (2tailed).
*. Correlation is significant at the 0.05 level (2tailed).
Table 5. Relationships among variables iodine, selenium, and thyroid hormones.
level. Besides moderate selenium deficiency, at least half of the study 
participants had severe or mild ID in both groups. Considering the 
age of our study participants, women with Hashimoto’s autoimmune 
thyroiditis, we might assume that they experienced iodine sufficiency or 
excess, or iodine insufficiency which could trigger autoimmune thyroid 
disease. Iodine is already recognized as established factor in the onset 
of thyroid autoimmunity. Also, in the study there was no association 
found between iodine and selenium, and iodine and thyroid hormones. 
Any possible interaction between selenium and iodine is still unclear. 
It is necessary to have adequate monitoring of urinary iodine levels on 
a population level in order to detect further trends. It is essential to 
ensure New Zealanders are achieving adequate iodine intake.
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